© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 19, 2021
The researchers unexpectedly found sustained visual improvement in both eyes, despite only 1 eye being treated with AAV.
A phase 2 study suggests treating the common diabetes comorbidity may be capable with the monoclonal antibody.
January 18, 2021
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
The randomized, blinded trial evaluated the safety and reactogenicity of aIIV3 and HD-IIV3 in adults 65 and older.
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
The role of many in psychiatry has changed during the COVID-19 pandemic.
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.
January 17, 2021
Personalized, daily self-reporting for patients could influence future therapeutic strategies.
Randomized controlled trials are needed to evaluate their efficacy in comparison with in-person group meetings.
Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.